BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22364165)

  • 1. The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.
    Rietz A; Spiers J
    Br J Pharmacol; 2012 Jun; 166(4):1225-43. PubMed ID: 22364165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Okadaic acid induces matrix metalloproteinase-9 expression in fibroblasts: crosstalk between protein phosphatase inhibition and β-adrenoceptor signalling.
    Rietz A; Volkov Y; Davies A; Hennessy M; Spiers JP
    Br J Pharmacol; 2012 Jan; 165(1):274-88. PubMed ID: 21718298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.
    Sulakhe PV; Vo XT
    Mol Cell Biochem; 1995; 149-150():103-26. PubMed ID: 8569720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitor.
    Deshmukh PA; Blunt BC; Hofmann PA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H792-9. PubMed ID: 17012362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
    Li WQ; Dehnade F; Zafarullah M
    J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
    Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
    Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
    Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites.
    Greif DM; Kou R; Michel T
    Biochemistry; 2002 Dec; 41(52):15845-53. PubMed ID: 12501214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
    Dufour A; Sampson NS; Zucker S; Cao J
    J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium.
    Gupta RC; Neumann J; Watanabe AM; Sabbah HN
    Biochem Pharmacol; 2002 Mar; 63(6):1069-76. PubMed ID: 11931839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
    Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
    Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.
    Adams DG; Coffee RL; Zhang H; Pelech S; Strack S; Wadzinski BE
    J Biol Chem; 2005 Dec; 280(52):42644-54. PubMed ID: 16239230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
    Kobayashi K; Arimura Y; Goto A; Okahara S; Endo T; Shinomura Y; Imai K
    J Pathol; 2006 Jul; 209(3):376-83. PubMed ID: 16552705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
    Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S
    J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors.
    Hupfeld CJ; Resnik JL; Ugi S; Olefsky JM
    J Biol Chem; 2005 Jan; 280(2):1016-23. PubMed ID: 15520010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Okadaic acid increases the phosphorylation state of alpha1A-adrenoceptors and induces receptor desensitization.
    Alcántara-Hernández R; García-Sáinz JA
    Eur J Pharmacol; 2005 Nov; 525(1-3):18-23. PubMed ID: 16297906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
    Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
    BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
    Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.